Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Convergent synthesis and evaluation of (18)F-labeled azulenic COX2 probes for cancer imaging.

Nolting DD, Nickels M, Tantawy MN, Yu JY, Xie J, Peterson TE, Crews BC, Marnett L, Gore JC, Pham W.

Front Oncol. 2013 Jan 3;2:207. doi: 10.3389/fonc.2012.00207. eCollection 2012.

2.

An in vivo molecular imaging probe (18)F-Annexin B1 for apoptosis detection by PET/CT: preparation and preliminary evaluation.

Wang MW, Wang F, Zheng YJ, Zhang YJ, Zhang YP, Zhao Q, Shen CK, Wang Y, Sun SH.

Apoptosis. 2013 Feb;18(2):238-47. doi: 10.1007/s10495-012-0788-0.

PMID:
23238992
3.

A novel aliphatic 18F-labeled probe for PET imaging of melanoma.

Liu H, Liu S, Miao Z, Jiang H, Deng Z, Hong X, Cheng Z.

Mol Pharm. 2013 Sep 3;10(9):3384-91. doi: 10.1021/mp400225s. Epub 2013 Aug 22.

4.

Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.

Hofmann S, Maschauer S, Kuwert T, Beck-Sickinger AG, Prante O.

Mol Pharm. 2015 Apr 6;12(4):1121-30. doi: 10.1021/mp500601z. Epub 2015 Mar 13.

PMID:
25748228
5.

Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.

Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE.

J Nucl Med. 2014 Jul;55(7):1178-84. doi: 10.2967/jnumed.114.137489. Epub 2014 May 22.

6.

Development of a clickable bimodal fluorescent/PET probe for in vivo imaging.

Paulus A, Desai P, Carney B, Carlucci G, Reiner T, Brand C, Weber WA.

EJNMMI Res. 2015 Dec;5(1):120. doi: 10.1186/s13550-015-0120-4. Epub 2015 Aug 19.

7.

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules.

Cheng Z, De Jesus OP, Namavari M, De A, Levi J, Webster JM, Zhang R, Lee B, Syud FA, Gambhir SS.

J Nucl Med. 2008 May;49(5):804-13. doi: 10.2967/jnumed.107.047381. Epub 2008 Apr 15.

8.

A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.

Matusiak N, Castelli R, Tuin AW, Overkleeft HS, Wisastra R, Dekker FJ, Prély LM, Bischoff R, van Waarde A, Dierckx RA, Elsinga PH.

Bioorg Med Chem. 2015 Jan 1;23(1):192-202. doi: 10.1016/j.bmc.2014.11.013. Epub 2014 Nov 15. Erratum in: Bioorg Med Chem. 2015 Apr 1;23(7):1660. Bischoff, Rainer P M [corrected to Bischoff, Rainer].

PMID:
25438884
9.

A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor.

Miao Z, Ren G, Jiang L, Liu H, Webster JM, Zhang R, Namavari M, Gambhir SS, Syud F, Cheng Z.

Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):1977-84. doi: 10.1007/s00259-011-1879-9. Epub 2011 Jul 15.

10.

Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.

Temma T, Nishigori K, Onoe S, Sampei S, Kimura I, Ono M, Saji H.

Nucl Med Biol. 2015 Feb;42(2):184-91. doi: 10.1016/j.nucmedbio.2014.10.006. Epub 2014 Oct 16.

PMID:
25457456
11.

Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.

Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.

Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19.

PMID:
23969085
12.

Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agent.

Ides J, Thomae D, Wyffels L, Vangestel C, Messagie J, Joossens J, Lardon F, Van der Veken P, Augustyns K, Stroobants S, Staelens S.

Nucl Med Biol. 2014 Jul;41(6):477-87. doi: 10.1016/j.nucmedbio.2014.03.019. Epub 2014 Mar 29.

PMID:
24768145
13.

PET of EGFR expression with an 18F-labeled affibody molecule.

Miao Z, Ren G, Liu H, Qi S, Wu S, Cheng Z.

J Nucl Med. 2012 Jul;53(7):1110-8. doi: 10.2967/jnumed.111.100842. Epub 2012 Jun 11.

14.

Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.

Ren G, Liu S, Liu H, Miao Z, Cheng Z.

Bioconjug Chem. 2010 Dec 15;21(12):2355-60. doi: 10.1021/bc100391a. Epub 2010 Nov 12.

15.

Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.

Harada N, Nishiyama S, Kanazawa M, Tsukada H.

J Labelled Comp Radiopharm. 2013 Sep;56(11):553-61. doi: 10.1002/jlcr.3056. Epub 2013 Jul 30.

PMID:
24285187
16.

Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.

Li Y, Liu Z, Lozada J, Wong MQ, Lin KS, Yapp D, Perrin DM.

Nucl Med Biol. 2013 Nov;40(8):959-66. doi: 10.1016/j.nucmedbio.2013.08.001. Epub 2013 Oct 3.

PMID:
24090672
17.

PET of malignant melanoma using 18F-labeled metallopeptides.

Ren G, Liu Z, Miao Z, Liu H, Subbarayan M, Chin FT, Zhang L, Gambhir SS, Cheng Z.

J Nucl Med. 2009 Nov;50(11):1865-72. doi: 10.2967/jnumed.109.062877. Epub 2009 Oct 16.

18.

In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.

Niedermoser S, Chin J, Wängler C, Kostikov A, Bernard-Gauthier V, Vogler N, Soucy JP, McEwan AJ, Schirrmacher R, Wängler B.

J Nucl Med. 2015 Jul;56(7):1100-5. doi: 10.2967/jnumed.114.149583. Epub 2015 May 14.

19.

Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agents.

Wang L, Zha Z, Qu W, Qiao H, Lieberman BP, Plössl K, Kung HF.

Nucl Med Biol. 2012 Oct;39(7):933-43. doi: 10.1016/j.nucmedbio.2012.03.007. Epub 2012 Apr 26.

20.

Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma.

Liu H, Liu S, Miao Z, Deng Z, Shen B, Hong X, Cheng Z.

J Med Chem. 2013 Feb 14;56(3):895-901. doi: 10.1021/jm301740k. Epub 2013 Jan 18.

Supplemental Content

Support Center